The Year in Lipid Disorders.

Format:

Book

Author/Creator:

Toth, Peter P.

Series:

Year in Lipid Disorders

Year in Lipid Disorders ; v.02

Language:

English

Subjects (All):

Hyperlipidemia.

Lipids--Metabolism--Disorders--Periodicals.

Lipids--Metabolism--Disorders.

Local Subjects:

Hyperlipidemia.

Lipids--Metabolism--Disorders--Periodicals.

Lipids--Metabolism--Disorders.

Physical Description:

1 online resource (333 p.)

Edition:

1st ed.

Place of Publication:

Oxford : Clinical Publishing, 2010.

Language Note:

English

Summary:

Lipid disorders are among the primary risk factors in developing atherosclerosis and heart disease. Providing an up-to-date insight into the latest research into lipid disorders, and the implications of this research for daily clinical practice, this collection includes an overview of the latest developments in this complex field by reviewing the most significant papers published in the medical journals on lipid disorders over the last eighteen months.

Contents:

Contents; Editors; Contributors; Part 1: Clinical aspects ofatherosclerotic disease; Chapter 1: Proprotein convertase subtilisin/kexin type 9 (PCSK9): molecular function and impact of its mutations and polymorphisms on cholesterol levels and related diseases; Chapter 2: Metabolic syndrome, diabetes and cardiovascular risk; Chapter 3: Diet and exercise in the prevention and treatment of diabetes and coronary heart disease; Chapter 4: Imaging developments in vascular disease; Part II: Lipids, lipoproteins and atherosclerosis

Chapter 5: Ezetimibe: mechanism of action update and recent controversiesChapter 6: Oxidative stress, lipoprotein oxidation and atherosclerosis; Chapter 7: Updating the metabolism of apolipoprotein B-100- containing lipoproteins in dyslipidaemia; Chapter 8: Triglycerides and atherosclerosis; Part III: Prevention and treatment strategies; Chapter 9: JUPITER: the crossroads between statin therapy, inflammation and cardiovascular risk reduction; Chapter 10: New clinical trials of lipid regulatingagents; Chapter 11: Statin myopathy

Chapter 12: Nuclear receptors (PPARs, LXRs and TRs) and their role in regulating lipid metabolismPart IV: Infection, inflammation and secondary causes of atherosclerosis; Chapter 13: Inflammation, inflammatory disease and coronary atherosclerosis; Chapter 14: Mechanisms of insulin resistance; Chapter 15: Haemostasis-dyslipidaemia interactions in coronary heart disease; Acronyms/abbreviations; Index of papers reviewed; General index

Notes:

Description based upon print version of record.

Description based on publisher supplied metadata and other sources.

ISBN:

9786612727429

9781282727427

1282727427

9781846926228

184692622X

OCLC:

693761617